Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions

Language
Published
2021

This document aims to provide interim guidance on the risks for fully vaccinated individuals to develop or transmit infection that will give rise to severe COVID-19 disease in the context of the current epidemiological and vaccine coverage situation in the EU/EEA. The document assesses the following questions: 1.What is the risk of developing severe COVID-19 for a fully vaccinated individual? 2.What is the risk of severe COVID-19 for an unvaccinated individual in contact with a fully vaccinated person who has recently been exposed to SARS-CoV-2 infection?